About this trial
This study aims to verify the results from our previous retrospective cohort analysis by establishing a database of well-characterised patients prospectively. The different prevalence of neurological disorders, abdominal, urological and obstetrical surgery, diarrhoea and other potential associated factors as well as the importance of abnormalities identified by 3D high resolution anorectal manometry (HARM) will be compared between subjects with feacal incontinence (FI), double incontinence (DI) and controls. Presence and severity of both FI and urinary incontinence (UI) will be evaluated by disease specific questionnaires. Measuring both disease severity and Quality of Life (QoL) is needed to determine the true impact of incontinence. Finally, the impact on quality of life will be compared between both groups.
Eligibility criteria
Qualifiers
Age > 18 years;
Self-reported faecal incontinence.
Disqualifiers
Impossibility to perform the anorectal manometry because of pain, stenosis or organic disease;
Active (peri)rectal inflammation, including abscess;
Pregnancy;
Inability to cooperate during the anorectal manometry
Trial design
Treatments tested in this trial
- Questionnaires